Expression/NN
of/IN
1,25(OH)2D3/NN
receptors/NNS
on/IN
alveolar/JJ
lymphocytes/NNS
from/IN
patients/NNS
with/IN
pulmonary/JJ
granulomatous/JJ
diseases/NNS
./.

1,25(OH)2D3/NN
is/VBZ
known/VBN
to/TO
be/VB
produced/VBN
at/IN
sites/NNS
of/IN
granulomatous/JJ
reactions/NNS
./.
=====
In/IN
order/NN
to/TO
characterize/VB
the/DT
cell/NN
types/NNS
that/WDT
are/VBP
targets/NNS
for/IN
this/DT
immunoregulatory/JJ
hormone/NN
,/,
we/PRP
have/VBP
evaluated/VBN
the/DT
expression/NN
of/IN
1,25(OH)2D3/NN
receptors/NNS
on/IN
peripheral/JJ
blood/NN
T-lymphocytes/NNS
and/CC
those/DT
recovered/VBN
from/IN
the/DT
lung/NN
by/IN
bronchoalveolar/JJ
lavage/NN
from/IN
patients/NNS
with/IN
pulmonary/JJ
granulomatous/JJ
diseases/NNS
(/(
tuberculosis/NN
and/CC
sarcoidosis/NN
)/)
and/CC
from/IN
normal/JJ
control/NN
subjects/NNS
using/VBG
combined/JJ
autoradiographic/JJ
and/CC
immunohistochemical/JJ
techniques/NNS
./.
=====
Lavage/NN
T-lymphocytes/NNS
from/IN
patients/NNS
with/IN
tuberculosis/NN
or/CC
with/IN
sarcoidosis/NN
,/,
but/CC
not/RB
those/DT
from/IN
normal/JJ
control/NN
subjects/NNS
,/,
expressed/VBD
1,25(OH)2D3/NN
receptors/NNS
as/IN
demonstrated/VBN
by/IN
binding/NN
of/IN
[3H]1,25(OH)2D3/NN
,/,
which/WDT
was/VBD
inhibited/VBN
by/IN
the/DT
presence/NN
of/IN
excess/JJ
unlabeled/JJ
1,25(OH)2D3/NN
,/,
but/CC
not/RB
by/IN
the/DT
presence/NN
of/IN
unlabeled/JJ
25/CD
(/(
OH/NN
)/)
D3/NN
(/(
receptor-positive/JJ
lymphocytes/NNS
:/:
sarcoidosis/NN
,/,
20/CD
+/-/CC
12/CD
%/NN
;/:
tuberculosis/NN
,/,
31/CD
+/-/CC
17/CD
%/NN
)/)
./.
=====
In/IN
contrast/NN
,/,
blood/NN
lymphocytes/NNS
from/IN
patients/NNS
with/IN
granulomatous/JJ
diseases/NNS
did/VBD
not/RB
express/VB
detectable/JJ
1,25(OH)2D3/NN
receptors/NNS
./.
=====
The/DT
percentage/NN
of/IN
lavage/NN
T-lymphocytes/NNS
expressing/VBG
1,25(OH)2D3/NN
receptors/NNS
was/VBD
significantly/RB
greater/JJR
for/IN
patients/NNS
with/IN
tuberculosis/NN
presenting/VBG
with/IN
isolated/VBN
hilar/JJ
adenopathy/JJ
than/IN
for/IN
patients/NNS
with/IN
pulmonary/JJ
infiltrates/NNS
and/or/CC
cavities/NNS
./.
=====
1,25(OH)2D3/NN
receptors/NNS
were/VBD
expressed/VBN
to/TO
a/DT
greater/JJR
extent/NN
on/IN
CD8+/JJ
T-lymphocytes/NNS
than/IN
on/IN
CD4+/JJ
T-lymphocytes/NNS
in/IN
sarcoidosis/NN
,/,
whereas/IN
a/DT
greater/JJR
proportion/NN
of/IN
CD4+/JJ
than/IN
of/IN
CD8+/JJ
T-lymphocytes/NNS
from/IN
patients/NNS
with/IN
tuberculosis/NN
were/VBD
receptor-positive/JJ
./.
=====
These/DT
findings/NNS
support/VBP
the/DT
conclusion/NN
that/IN
the/DT
interaction/NN
of/IN
1,25(OH)2D3/NN
with/IN
its/PRP$
receptor/NN
on/IN
T-lymphocytes/NNS
may/MD
play/VB
an/DT
important/JJ
role/NN
in/IN
the/DT
regulation/NN
of/IN
granulomatous/JJ
reactions/NNS
,/,
but/CC
because/IN
these/DT
receptors/NNS
are/VBP
expressed/VBN
on/IN
different/JJ
lymphocyte/NN
populations/NNS
,/,
the/DT
net/JJ
effect/NN
of/IN
this/DT
potent/JJ
immunoregulatory/JJ
molecule/NN
is/VBZ
likely/RB
different/JJ
in/IN
sarcoidosis/NN
and/CC
tuberculosis/NN
./.